VOICED : Esteroide reduce mortalidad de pacientes graves de covid-19, según prometedor estudio

A clinical trial led by Oxford University found that dexamethasone, an anti-inflammatory steroid, significantly reduces mortality in severe COVID-19 cases. The drug decreased deaths by 35% in patients on ventilators and by 20% in those receiving oxygen. However, it showed no benefit for patients not requiring respiratory support. Following these findings, the UK government began immediate distribution of dexamethasone, which is cost-effective and widely available. Another study highlighted the lower incidence of COVID-19 among young people, with those under 20 having half the risk of infection compared to older individuals. Models developed by the London School of Hygiene and Tropical Medicine indicated that only 20% of youths aged 10-19 may show symptoms, compared to 70% of those over 70.

What was the primary finding of the clinical trial led by Oxford University regarding dexamethasone?

• It was ineffective for all COVID-19 patients.

• It had no effect on patients with mild symptoms.

• It reduced deaths in critically ill patients on ventilators.

• It increased mortality in COVID-19 patients.

What is the main benefit of dexamethasone according to the clinical trial?

• It reduces the need for oxygen therapy.

• It lowers mortality in severe cases.

• It is a cure for COVID-19.

• It prevents COVID-19 infection.

What action did the UK government take after the trial results of dexamethasone?

• They banned the use of dexamethasone.

• They decided to conduct more trials.

• They delayed the use of dexamethasone.

• They immediately started using dexamethasone.

According to the study, how does the likelihood of contracting COVID-19 compare between those under 20 and older individuals?

• Those under 20 are more likely to contract the virus.

• Those under 20 have the same likelihood as older individuals.

• Those under 20 are less likely to contract the virus.

• Age does not affect the likelihood of contracting the virus.

What percentage of young people aged 10 to 19 are likely to show symptoms of COVID-19?

• Three in five

• Seven in ten

• One in five

• Five in five